Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Lxn | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LXN mRNA | CTD | PMID:22079256 | Lxn | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | o and p'-DDT results in decreased expression of LXN mRNA | CTD | PMID:18204070 | Lxn | Rat | 1,1-dichloroethene | increases expression | ISO | Lxn (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of LXN mRNA | CTD | PMID:26682919 | Lxn | Rat | 1,2-dichloroethane | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of LXN mRNA | CTD | PMID:28960355 | Lxn | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Lxn (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of LXN mRNA | CTD | PMID:22206623 | Lxn | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LXN mRNA | CTD | PMID:17942748 | Lxn | Rat | 17beta-estradiol | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LXN mRNA more ... | CTD | PMID:17404688 more ... | Lxn | Rat | 17beta-estradiol | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Estradiol results in decreased expression of LXN mRNA | CTD | PMID:19619570 more ... | Lxn | Rat | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LXN mRNA | CTD | PMID:19619570 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LXN mRNA | CTD | PMID:33387578 and PMID:34747641 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LXN mRNA | CTD | PMID:22298810 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LXN mRNA | CTD | PMID:17942748 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LXN mRNA | CTD | PMID:17517823 | Lxn | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LXN mRNA | CTD | PMID:19619570 | Lxn | Rat | 2-butoxyethanol | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of LXN mRNA | CTD | PMID:19812364 | Lxn | Rat | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Lxn (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of LXN promoter | CTD | PMID:26251327 | Lxn | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Lxn (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of LXN mRNA | CTD | PMID:26251327 | Lxn | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of LXN protein | CTD | PMID:34915118 | Lxn | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LXN mRNA | CTD | PMID:16997883 | Lxn | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of LXN mRNA | CTD | PMID:30723492 | Lxn | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LXN mRNA | CTD | PMID:36041667 | Lxn | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Lxn (Mus musculus) | 6480464 | Fenretinide results in increased expression of LXN mRNA | CTD | PMID:28973697 | Lxn | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | LXN (Homo sapiens) | 6480464 | Decitabine affects the expression of LXN mRNA | CTD | PMID:17145863 | Lxn | Rat | 5-fluorouracil | affects response to substance | ISO | LXN (Homo sapiens) | 6480464 | LXN protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 | Lxn | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of LXN mRNA | CTD | PMID:30047161 | Lxn | Rat | 8-Br-cAMP | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LXN mRNA | CTD | PMID:16997883 | Lxn | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of LXN mRNA | CTD | PMID:28959563 | Lxn | Rat | aflatoxin B1 | increases expression | ISO | Lxn (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of LXN mRNA | CTD | PMID:19770486 | Lxn | Rat | alachlor | increases expression | EXP | | 6480464 | alachlor results in increased expression of LXN mRNA | CTD | PMID:12419858 | Lxn | Rat | all-trans-retinoic acid | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Tretinoin results in increased expression of LXN mRNA | CTD | PMID:23830798 | Lxn | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of LXN mRNA | CTD | PMID:30047161 | Lxn | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of LXN mRNA | CTD | PMID:16483693 | Lxn | Rat | arsenite(3-) | increases expression | ISO | Lxn (Mus musculus) | 6480464 | arsenite results in increased expression of LXN protein | CTD | PMID:37955338 | Lxn | Rat | azathioprine | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Azathioprine results in increased expression of LXN mRNA | CTD | PMID:19192274 | Lxn | Rat | benzo[a]pyrene | affects expression | ISO | LXN (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the expression of LXN mRNA | CTD | PMID:21714911 | Lxn | Rat | benzo[a]pyrene | affects methylation | ISO | LXN (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LXN promoter | CTD | PMID:27901495 | Lxn | Rat | benzo[a]pyrene | increases expression | ISO | Lxn (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LXN mRNA | CTD | PMID:19770486 more ... | Lxn | Rat | benzo[a]pyrene diol epoxide I | affects expression | ISO | LXN (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | Lxn | Rat | benzo[b]fluoranthene | increases expression | ISO | Lxn (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of LXN mRNA | CTD | PMID:26377693 | Lxn | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LXN mRNA | CTD | PMID:18164116 | Lxn | Rat | biochanin A | increases expression | ISO | LXN (Homo sapiens) | 6480464 | biochanin A results in increased expression of LXN mRNA | CTD | PMID:12111696 | Lxn | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LXN mRNA | CTD | PMID:25181051 | Lxn | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LXN mRNA | CTD | PMID:36041667 | Lxn | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LXN mRNA | CTD | PMID:30816183 and PMID:32528016 | Lxn | Rat | bisphenol A | increases expression | ISO | LXN (Homo sapiens) | 6480464 | bisphenol A results in increased expression of LXN mRNA | CTD | PMID:27685785 | Lxn | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LXN mRNA | CTD | PMID:36041667 | Lxn | Rat | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of LXN protein | CTD | PMID:28903499 | Lxn | Rat | calcitriol | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of LXN mRNA | CTD | PMID:21592394 | Lxn | Rat | calcitriol | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Calcitriol results in increased expression of LXN mRNA | CTD | PMID:21592394 | Lxn | Rat | choline | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LXN gene | CTD | PMID:20938992 | Lxn | Rat | cobalt dichloride | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of LXN mRNA | CTD | PMID:19320972 | Lxn | Rat | copper(II) chloride | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of LXN mRNA | CTD | PMID:38568856 | Lxn | Rat | crocidolite asbestos | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of LXN mRNA | CTD | PMID:18687144 | Lxn | Rat | cyclosporin A | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of LXN mRNA | CTD | PMID:19770486 | Lxn | Rat | dexamethasone | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LXN mRNA | CTD | PMID:16997883 | Lxn | Rat | dexamethasone | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of LXN mRNA | CTD | PMID:25047013 | Lxn | Rat | dibenz[a,h]anthracene | increases expression | ISO | Lxn (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | Lxn | Rat | diclofenac | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Diclofenac results in increased expression of LXN mRNA | CTD | PMID:19192274 | Lxn | Rat | dioxygen | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LXN mRNA | CTD | PMID:30529165 | Lxn | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of LXN mRNA | CTD | PMID:21551480 | Lxn | Rat | doxorubicin | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LXN mRNA | CTD | PMID:29803840 | Lxn | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of LXN mRNA | CTD | PMID:29391264 | Lxn | Rat | etoposide | increases response to substance | ISO | Lxn (Mus musculus) | 6480464 | LXN protein results in increased susceptibility to Etoposide | CTD | PMID:25341047 | Lxn | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of LXN mRNA | CTD | PMID:18035473 | Lxn | Rat | folic acid | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LXN gene | CTD | PMID:20938992 | Lxn | Rat | formaldehyde | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of LXN mRNA | CTD | PMID:23649840 | Lxn | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of LXN mRNA | CTD | PMID:27387713 | Lxn | Rat | genistein | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Genistein results in decreased expression of LXN mRNA | CTD | PMID:23019147 | Lxn | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of LXN mRNA | CTD | PMID:33387578 | Lxn | Rat | glycidyl methacrylate | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | glycidyl methacrylate results in decreased expression of LXN protein | CTD | PMID:36641056 | Lxn | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of LXN mRNA | CTD | PMID:21396975 | Lxn | Rat | L-ascorbic acid | increases expression | ISO | Lxn (Mus musculus) | 6480464 | Ascorbic Acid results in increased expression of LXN mRNA and Ascorbic Acid results in increased expression of LXN protein | CTD | PMID:22139585 | Lxn | Rat | L-methionine | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LXN gene | CTD | PMID:20938992 | Lxn | Rat | lucanthone | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Lucanthone results in increased expression of LXN mRNA | CTD | PMID:21148553 | Lxn | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of LXN mRNA | CTD | PMID:30047161 | Lxn | Rat | methotrexate | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Methotrexate results in increased expression of LXN mRNA | CTD | PMID:19192274 | Lxn | Rat | methylmercury chloride | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of LXN mRNA | CTD | PMID:28001369 | Lxn | Rat | mifepristone | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Mifepristone results in increased expression of LXN mRNA | CTD | PMID:17584828 | Lxn | Rat | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of LXN mRNA | CTD | PMID:21515302 | Lxn | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LXN mRNA | CTD | PMID:25566086 | Lxn | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Lxn (Mus musculus) | 6480464 | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LXN mRNA] | CTD | PMID:25566086 | Lxn | Rat | N-ethyl-N-nitrosourea | increases expression | EXP | | 6480464 | Ethylnitrosourea results in increased expression of LXN mRNA | CTD | PMID:15954086 | Lxn | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LXN mRNA | CTD | PMID:18164116 | Lxn | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LXN mRNA | CTD | PMID:25729387 | Lxn | Rat | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of LXN mRNA | CTD | PMID:25729387 | Lxn | Rat | paracetamol | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of LXN mRNA | CTD | PMID:21420995 | Lxn | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of LXN mRNA | CTD | PMID:19162173 | Lxn | Rat | piroxicam | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Piroxicam results in increased expression of LXN mRNA | CTD | PMID:19192274 | Lxn | Rat | potassium chromate | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of LXN mRNA | CTD | PMID:22079256 | Lxn | Rat | potassium chromate | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LXN mRNA | CTD | PMID:22079256 | Lxn | Rat | progesterone | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of LXN mRNA | CTD | PMID:17404688 | Lxn | Rat | resveratrol | increases expression | ISO | Lxn (Mus musculus) | 6480464 | resveratrol results in increased expression of LXN protein | CTD | PMID:25505154 | Lxn | Rat | sodium arsenite | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LXN mRNA | CTD | PMID:34032870 and PMID:38568856 | Lxn | Rat | sodium arsenite | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of LXN mRNA | CTD | PMID:37682722 | Lxn | Rat | sodium aurothiomalate | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Gold Sodium Thiomalate results in increased expression of LXN mRNA | CTD | PMID:19192274 | Lxn | Rat | sodium fluoride | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of LXN protein | CTD | PMID:28918527 | Lxn | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of LXN mRNA | CTD | PMID:30047161 | Lxn | Rat | sulforaphane | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of LXN mRNA | CTD | PMID:31838189 | Lxn | Rat | sunitinib | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LXN mRNA | CTD | PMID:31533062 | Lxn | Rat | temozolomide | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of LXN mRNA | CTD | PMID:31758290 | Lxn | Rat | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of LXN mRNA | CTD | PMID:21515302 | Lxn | Rat | testosterone | multiple interactions | ISO | LXN (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of LXN mRNA | CTD | PMID:21592394 | Lxn | Rat | testosterone | increases expression | ISO | LXN (Homo sapiens) | 6480464 | Testosterone results in increased expression of LXN mRNA | CTD | PMID:21592394 | Lxn | Rat | tetrachloromethane | affects expression | ISO | Lxn (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of LXN mRNA | CTD | PMID:17484886 | Lxn | Rat | thiram | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Thiram results in decreased expression of LXN mRNA | CTD | PMID:38568856 | Lxn | Rat | titanium dioxide | decreases methylation | ISO | Lxn (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LXN gene | CTD | PMID:35295148 | Lxn | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of LXN mRNA | CTD | PMID:25729387 | Lxn | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LXN mRNA | CTD | PMID:25729387 | Lxn | Rat | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of LXN mRNA | CTD | PMID:30047161 | Lxn | Rat | trimellitic anhydride | increases expression | ISO | Lxn (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of LXN mRNA | CTD | PMID:19042947 | Lxn | Rat | triphenyl phosphate | affects expression | ISO | LXN (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of LXN mRNA | CTD | PMID:37042841 | Lxn | Rat | triptonide | decreases expression | ISO | Lxn (Mus musculus) | 6480464 | triptonide results in decreased expression of LXN mRNA | CTD | PMID:33045310 | Lxn | Rat | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of LXN mRNA | CTD | PMID:21515302 | Lxn | Rat | valproic acid | increases methylation | ISO | LXN (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of LXN gene | CTD | PMID:29154799 | Lxn | Rat | valproic acid | decreases expression | ISO | LXN (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of LXN mRNA | CTD | PMID:23179753 and PMID:28001369 | Lxn | Rat | valproic acid | affects expression | ISO | LXN (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LXN mRNA | CTD | PMID:25979313 | Lxn | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of LXN mRNA | CTD | PMID:23034163 | |